Recalls / Brands / Mirtazapine
Mirtazapine
5 FDA drug recalls involving brand “Mirtazapine” — 2 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2020-03-18 | Class II | Mirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, N | Aurobindo Pharma USA Inc. |
| 2019-11-20 | Class I | Mirtazapine Tablets, USP, 15 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayto | AuroMedics Pharma LLC |
| 2019-11-20 | Class I | Mirtazapine Tablets, USP, 7.5 mg, 500-count tablets, Rx only, Distributed by: Aurobindo Pharma USA, Inc. Dayt | AuroMedics Pharma LLC |
| 2017-01-27 | Class II | Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc | Mylan Institutional, Inc. (d.b.a. UDL Laboratories) |
| 2017-01-19 | Class II | Mirtazapine Tablets, USP 45 mg, a) 30 count, b) 100 count and c) 500 count bottles, Rx only, Mylan Pharmaceuti | Mylan Pharmaceuticals Inc. |